Are Monthly PrEP Injections (Rather Than Once-a-Day Pills) In HIV Prevention’s Near Future?
CDC Scientists have found that the long-acting investigational ARV GSK744 can fully prevent SIV transmission in female pigtail macaques. But how long will it be until we can test on the human form?
Here are salvos from a new AIDS battle:
-Calling a young, HIV-negative gay man a “Truvada whore” simply for choosing a prevention option with a higher efficacy rate than condoms.
-Becoming indignant when someone says AIDS is still a gay problem.
-Turning to the police when you find out the guy that just jilted you is HIV-positive.
-Putting “I’m clean, ub2” in your online profile.
-HIV-negative guys barebacking with those who tell them they are negative and shunning the few brave ones who admit they’re positive.
Redefining Sex With HIV:
The CDC will stop using "unprotected sex" for "sex without condoms" in its HIV/AIDS research after a letter by HIV PJA argued that not all condomless sex between MSMs has a heightened HIV risk (—shout out to you PrEP!). Thoughts?
The Fury of the PrEP Debate and Facts to Win It
In his latest blog post, Mark S. King goes over the most persistent objections to pre-exposure prophylaxis (PrEP) and the real facts to defeat the haters.
"Do we really know the side effects?" "Won’t PrEP just encourage slutty behavior?" "Can everybody even get the drugs?" "Won’t it create resistant strains of HIV?" Oh. Touche.
One More Study Shows PrEP Doesn’t Lead to Riskier Sex
PrEP was approved in 2012 as an HIV prevention tool that can reduce the risk of transmission by more than 90% if used correctly. However, the antiretroviral has remained controversial, and sparsely used, in no small part because of concerns that it will lead to sexual risk bingeing.
3 out of 4 Infectious Disease Docs Say They Support PrEP. So Why Do Only 9% Write ‘Scripts?
The use of HIV antiretrovirals as pre-exposure prophylaxis to prevent the transmission of the virus before it manifests is proven to work, and apparently vastly supported in the medical community. But when it comes to actually making the decision with patients, most docs back out. Is it an education or moral flaw?
Stop Bludgeoning Young Gay Men with Our AIDS Tragedy
In his latest blog, Mark S. King writes:
"Lesley was my closest friend to become sick in the 1980′s, and he fought bravely until his death from AIDS…I often write about him, the first of many friends lost to the epidemic.
But there’s something I will not do. I will not dig up Lesley’s body and beat young gay men with his corpse. Lesley didn’t perish so I could use him as a scare tactic. He wasn’t a cautionary tale. He wasn’t a martyr. He was a man with the same passions and faults as anyone else, and I won’t use his death as a blunt instrument.”
PrEP involves the use of any anti-HIV agent before, during and usually after sex to prevent infection. Today, PrEP refers primarily to taking the HIV treatment Truvada every day along with using condoms. What we know about PrEP is that even in people who don’t use condoms regularly, it can work amazingly well if taken exactly as prescribed. Two studies have found that daily use could be almost 100-percent effective.
Treatment News: PrEP Did Not Increase Sexual Risks in Study of Gay Men
Pre exposure prophylaxis, in which an HIV antiretrovirals are taken daily by HIV-negative people at high risk for infection, has been shown in recent research with MSM to significantly lower the risk of transmission. A major concern, however, is that those taking PrEP will consider themselves more invincible to infection and might take more sexual risks. This study says otherwise.